International Sc2.0 Project On Track to Build World’s First Synthetic Yeast Genome

March 9th, 2017 – Shenzhen. A team from the international Synthetic Yeast Genome Project (Sc2.0 project) have announced the completion of the de novo redesign and synthesis of five more chromosomes of Saccharomyces cerevisiae; chromosomes II, V, VI, X and XII. The researchers also performed an in-depth, multi-dimensional analysis on the yeast strain, and confirmed that the phenotype of the synthetic yeast strain is consistent to that of the wild-type.

BGI Opens Seattle Office for North America Expansion

BGI, a leading global genomics organization headquartered in Shenzhen, announced it is expanding its international operations with the formation of a new division, BGI Groups USA, to be based in Seattle. BGI is engaged in scientific research, genomic sequencing, precision medicine, agriculture, bioinformatics and related technologies with a vision to use genomics to benefit humanity.

BGI and British Columbia Organizations to Collaborate on Precision Medicine

BGI and five British Columbia-based biomedical and healthcare organizations have allied on personalized medicine. The Canadian partners include Providence Health Care, St. Paul’s Foundation, the Vancouver Prostate Centre, Genome BC, and Deloitte. Together, the organizations will create “health centers of excellence” in Shenzen, China, where BGI is based, and Vancouver, British Columbia.

China National Genebank Officially Opens

Official opening of the China National GeneBank (CNGB) marks a new phase in Chinese-International genomics collaboration, providing scientists from across the world with access to one of the world’s most comprehensive and sophisticated biorepositories, with the goal of enabling breakthroughs in human health research and contributing to global biodiversity conservation efforts.

Making History: 60 Million Years of Fungus Farming in Ants

BGI and the Centre for Social Evolution in Copenhagen (CSE) publish joint study in Nature Communications revealing the genetic changes that enabled fungus farming ants and their cultivars to be so successful. Read our press release or contact us to discover how we can help with your research project.

Ranomics Partners with BGI to Classify Variants of Unknown Significance

BGI, global leader in genomics research and clinical applications, is actively using functional studies data provided by biotech startup, Ranomics, for gene variant classification. Ranomics’ database offers experimental data about genetic Variants of Unknown Significance (VUS), providing new insights into the function of VUS in model organisms.